In this episode of Data in Biotech, host Ross Katz talks with Jesper Ryge, Director of Computational Biology at Merck Germany. Jesper shares his journey from neuroscience labs to leading computational teams, offering deep insights into disease modeling, target discovery, and multi-omics integration. Discover how AI and spatial transcriptomics are shaping the future of pharma R&D.

What You'll Learn in This Episode

>> How single-cell and spatial transcriptomics enhance disease mechanism discovery

>> Why data integration and knowledge graphs are critical for target validation

>> How computational biology teams interface with wet lab research

>> What makes Merck Germany's data strategy unique in biotech

>> How generative AI is changing how pharma interprets complex datasets

Meet Our Guest

Jesper Ryge is Director of Computational Biology at Merck Germany. A biophysicist by training, he brings deep expertise in neuroscience, single-cell analysis, and bioinformatics to pharmaceutical R&D.

About The Host

Ross Katz is Principal and Data Science Lead at CorrDyn. Ross specializes in building intelligent data systems that empower biotech and healthcare organizations to extract insights and drive innovation.

Connect with Our Guest:

Sponsor: CorrDyn, a data consultancy
Find out more about Merck
Connect with Jesper Ryge on LinkedIn

Connect with Us:

Follow the podcast for more insightful discussions on the latest in biotech and data science.
Subscribe and leave a review if you enjoyed this episode!
Connect with Ross Katz on LinkedIn

Sponsored by…

This episode is brought to you by CorrDyn, the leader in data-driven solutions for biotech and healthcare. Discover how CorrDyn is helping organizations turn data into breakthroughs at CorrDyn.

#19 Chelsea Manning, crowdfunding and cricket strikes